Global Clinical Diagnostics Automation Industry
NEW YORK, July 3, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Clinical Diagnostics Automation Industryhttp://www.reportlinker.com/p0552746/Global-Clinical-Diagnostics-Automation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_
This report analyzes the worldwide markets for Clinical Diagnostics Automation in US$ Million by the following Product Segments: Automated Analyzers, Stand-alone Automation, and Total Lab Automation. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 62 companies including many key and niche players such as Abaxis, Inc., Abbott Diagnostics, Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Caliper Life Sciences, Inc., Diagnostica Stago, HORIBA ABX S.A.S., Hudson Robotics, Inc., Ortho Clinical Diagnostics, Inc., QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, Inc., Sysmex America, Inc., Tecan Group Ltd., Thermo Fisher Scientific, Inc., and Vital Scientific B.V. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-3Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Market Segmentation I-4Automated Analyzers I-4Stand-Alone Automation I-4Total Laboratory Automation I-4II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW II-1
Clinical Diagnostics Automation: A Global Insight II-1
The Road Ahead for Clinical Diagnostics Automation II-1
Growth Drivers in Lab Automation Market - A Snapshot II-2
Major Trends in Laboratory Automation Market II-2
Major Issues and Challenges in the Industry II-3
Automation - A Panacea to the Laboratories' Plight II-4
End-User and Technology-Led Aspects Drive Demand for Automation II-4
Automation - The Prime Solution to Enhance Laboratory Efficiency II-5
Total Laboratory Automation - Only Good Enough for Large
Hospitals II-5
Large Hospitals See Good Return on Investments by TLA II-5
Issues Continue to Plague Large Scale Automation Solutions II-6
Modular Automation Surges Ahead of TLA in Adoption II-6
Demand for POC Testing Rises II-7
POC Analyzers Looming Central Labs II-7
POC Testing - Drivers and Challenges II-7
Recession Halts Momentum in Lab Automation Market II-8
Regulatory Environment II-8
2. CLINICAL DIAGNOSTICS AUTOMATION - AN OVERVIEW II-9Laboratory Automation: Order of the Day II-9Benefits of Laboratory Automation II-9Introduction to Clinical Diagnostics Automation II-9Evolution of Clinical Diagnostics Automation II-10Components of Laboratory Automation System II-10Typical Diagnostic Laboratory Structure II-11Laboratory Control and Information System II-11Sample Storage II-11Sample Preparation II-12Transportation II-12Analysis II-12Clinical Diagnostics Automation by Market Segment II-12Automated Analyzers II-12Stand-Alone Automation II-12Total Laboratory Automation (TLA) II-13Limitations of TLA Systems II-13Modular Automation: Emerging Alternative II-13Total Laboratory Automation (TLA) Vs. Modular LaboratoryAutomation II-14Decentralized Testing Gains Importance II-14Advantages of POC Testing Over Centralized Laboratory Testing II-14Cost Analysis of POC Testing Vs. Laboratory Testing II-15Cost Savings through Space Savings II-15Major Components of Multi-Step Automation Process II-15Consolidation of Workstation II-15Information Management II-16
3. PRODUCT INTRODUCTIONS/INNOVATIONS II-17
Sysmex to Unveil Cell Image Analysis Portfolio II-17
BD Introduces Innova™ and InocuLAB Platforms II-17
HORIBA Medical Introduces Pentra C200 Compact Chemistry Analyzer II-18
Biocare Medical Introduces Automated Slide Stainer II-18
Roche Unveils Cobas 4800 System II-19
Siemens Introduces VersaCell™ and other Lab Automation Systems II-19
Sysmex America to Launch Sysmex TS-2000 Tube Sorter II-20
Randox Introduces Semi-Automated Analyzer II-20
QIAGEN Expands Diagnostic Instruments Portfolio II-20
Roche Receives CE Mark Certification for Cobas 8000 Modular
Analyzer II-20
4. PRODUCT INTRODUCTIONS/INNOVATIONS - A HISTORIC PERSPECTIVEBUILDER II-22IDH to Launch Products for Automated Diagnostic Analyzer II-22Caliper Unveils Automated Ensemble and Reprise Systems II-22bioMérieux to Launch Full Microbiology Laboratory AutomationSolutions II-22Magellan and Subsidiaries to Roll Out Automated Systems andDiagnostic Assays II-23Transasia Bio-Medicals Unveils Automated Chemistry Analyzer II-23Tecan Develops Cavro Omni Robot II-23Abbott to Showcase ARCHITECT® ci4100TM Integrated System II-24Horiba Unveils Two Laboratory Automation Systems II-24Siemens Healthcare Diagnostics Launches MicroScan WalkAwayplus Systems II-24Luminex to Introduce Innovative Bead-based Multiplexing Solution II-25
5. RECENT INDUSTRY ACTIVITY II-26
Danaher Acquires Beckman Coulter II-26
PerkinElmer Takes Over Caliper Life Sciences II-26
Roche Acquires PVT Probenverteiltechnik to Expand Clinical
Diagnostics Automation Portfolio II-26
Tecan Inks Global Manufacture and Supply Agreement with Enigma II-27
bioMérieux Inks Product Co-development and Marketing Agreement
with Philips II-27
NEXUS Snaps Up REMP from Tecan Group II-27
STRATEC Acquires US-based Ballista II-28
Sysmex America and Amerinet Ink Hematology Contract Agreement II-28
IRIS' Body Fluids Module Obtains FDA Clearance for Synovial
Fluid Analysis II-29
IRIS International Acquires Bench-Top Instrument Platform from
BioMicro Systems II-29
Sysmex Canada and EORLA Ink Capital Equipment and Vendor
Supply Service Agreements II-29
Thermo Fisher Scientific to Acquire B-R-A-H-M-S Holding II-30
Beckman Coulter Takes over Olympus' Diagnostic Business II-30
Tecan and Hologic Ink OEM Agreement II-31
BD Takes Over HandyLab II-31
Pievesestina-Located Clinical Lab Selects FlexLab Automation
System II-31
Hudson Control Group Adopts Original Name II-31
Abbott Obtains FDA Approval for PRISM HIV O Plus Test II-32
Ortho Clinical Establishes Remote Monitoring Center in France II-32
bioMerieux UK Bags Contract from The Royal Wolverhampton
Hospitals NHS Trust II-33
Bio-Reference and Sysmex America Enter Sole Source Agreement II-33
6. STRATEGIC CORPORATE DEVELOPMENTS - A HISTORIC PERSPECTIVE BUILDER II-34Sysmex America Receives Approval from US FDA II-34Roche to Take Over Ventana Medical Systems II-34Johnson & Johnson Nordic Takes Over Amic II-34ELITech Group Acquires Vital Scientific II-34Bio-Rad Inks Joint Marketing Agreement with Siemens MedicalSolutions II-35Siemens Medical Solutions Diagnostics Extends Agreement withSysmex America II-35RFCL Snaps Up Wipro BioMed II-35Siemens Medical Solutions Acquired Dade Behring II-36
7. FOCUS ON SELECT GLOBAL PLAYERS II-37
Abaxis, Inc. (USA) II-37
Abbott Diagnostics (USA) II-37
Beckman Coulter, Inc. (USA) II-37
Becton, Dickinson and Company (USA) II-38
bioMérieux SA (France) II-38
Bio-Rad Laboratories, Inc. (USA) II-39
Caliper Life Sciences, Inc. (USA) II-39
Diagnostica Stago (France) II-39
HORIBA ABX S.A.S. (France) II-40
Hudson Robotics, Inc. (USA) II-40
Ortho Clinical Diagnostics, Inc. (USA) II-40
QIAGEN (USA) II-40
Roche Diagnostics (USA) II-41
Siemens Healthcare Diagnostics, Inc. (USA) II-41
Sysmex America, Inc. (USA) II-42
Tecan Group Ltd. (Switzerland) II-42
Thermo Fisher Scientific, Inc. (USA) II-42
Vital Scientific B.V. (The Netherlands) II-43
8. GLOBAL MARKET PERSPECTIVE II-44Table 1: World Recent Past, Current and Future Analysis forClinical Diagnostics Automation by Geographic Region - US,Europe, and Rest of World Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2009 through2017 (includes corresponding Graph/Chart) II-44
Table 2: World Historic Review for Clinical Diagnostics
Automation by Geographic Region - US, Europe, and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2003 through 2008 (includes
corresponding Graph/Chart) II-45
Table 3: World 15-Year Perspective for Clinical DiagnosticsAutomation by Geographic Region - Percentage Breakdown ofDollar Sales for US, Europe, and Rest of World Markets forYears 2003, 2011 and 2017 (includes corresponding Graph/Chart) II-46
Table 4: World Recent Past, Current and Future Analysis for
Automated Analyzers by Geographic Region - US, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-47
Table 5: World Historic Review for Automated Analyzers byGeographic Region - US, Europe, and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2003 through 2008 (includes correspondingGraph/Chart) II-48
Table 6: World 15-Year Perspective for Automated Analyzers by
Geographic Region - Percentage Breakdown of Dollar Sales for
US, Europe, and Rest of World Markets for Years 2003, 2011 and
2017 (includes corresponding Graph/Chart) II-49
Table 7: World Recent Past, Current and Future Analysis forStand-alone Automation by Geographic Region - US, Europe, andRest of World Markets Independently Analyzed with Annual SalesFigures in US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) II-50
Table 8: World Historic Review for Stand-alone Automation by
Geographic Region - US, Europe, and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) II-51
Table 9: World 15-Year Perspective for Stand-alone Automationby Geographic Region - Percentage Breakdown of Dollar Salesfor US, Europe, and Rest of World Markets for Years 2003, 2011and 2017 (includes corresponding Graph/Chart) II-52
Table 10: World Recent Past, Current and Future Analysis for
Total Lab Automation by Geographic Region - US, Europe, and
Rest of World Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) II-53
Table 11: World Historic Review for Total Lab Automation byGeographic Region - US, Europe, and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2003 through 2008 (includes correspondingGraph/Chart) II-54
Table 12: World 15-Year Perspective for Total Lab Automation
by Geographic Region - Percentage Breakdown of Dollar Sales
for US, Europe, and Rest of World Markets for Years 2003, 2011
and 2017 (includes corresponding Graph/Chart) II-55
III. MARKET
1. THE UNITED STATES III-1
A.Market Analysis III-1
Automation Industry: At a Glance III-1
Major Drivers of Lab Automation Market III-1
Regulations Dictate Technological Changes in Laboratories III-1
Product Launches III-2
Strategic Corporate Developments III-6
Focus on Select Major Players III-11
B.Market Analytics III-16
Table 13: The US Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand- alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-16
Table 14: The US Historic Review for Clinical DiagnosticsAutomation by Product Segment - Automated Analyzers, TotalLab Automation, and Stand-alone Automation IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2003 through 2008 (includes corresponding Graph/Chart) III-17
Table 15: The US 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011
and 2017 (includes corresponding Graph/Chart) III-18
2. EUROPE III-19A.Market Analysis III-19European Clinical Diagnostics Automation Market: A Prelude III-19Economic Factors - Key Drivers to Growth III-20Manufacturers Face Significant Challenges III-20Future Trends III-20Automation Supports Growth in West European IVD Market III-20Product Launches III-21Strategic Corporate Developments III-22Focus on Select European Players III-26B.Market Analytics III-28Table 16: European Recent Past, Current and Future Analysisfor Clinical Diagnostics Automation by Product Segment -Automated Analyzers, Total Lab Automation, and Stand-aloneAutomation Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-28
Table 17: European Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-29
Table 18: European 15-Year Perspective for ClinicalDiagnostics Automation by Product Segment - PercentageBreakdown of Dollar Sales for Automated Analyzers, Total LabAutomation, and Stand-alone Automation for Years 2003, 2011,and 2017 (includes corresponding Graph/Chart) III-30
Table 19: European Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Geographic Region -
France, Germany, Italy, UK, Spain, and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-31
Table 20: European Historic Review for Clinical DiagnosticsAutomation by Geographic Region - France, Germany, Italy,UK, Spain, and Rest of Europe Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2003through 2008 (includes corresponding Graph/Chart) III-32
Table 21: European 15-Year Perspective for Clinical
Diagnostics Automation by Geographic Region - Percentage
Breakdown of Dollar Sales for France, Germany, Italy, UK,
Spain, and Rest of Europe Markets for Years 2003, 2011 and
2017 (includes corresponding Graph/Chart) III-33
2a. FRANCE III-34A.Market Analysis III-34Product Launches III-34B.Market Analytics III-36Table 22: French Recent Past, Current and Future Analysisfor Clinical Diagnostics Automation by Product Segment -Automated Analyzers, Total Lab Automation, and Stand-aloneAutomation Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-36
Table 23: French Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-37
Table 24: French 15-Year Perspective for ClinicalDiagnostics Automation by Product Segment - PercentageBreakdown of Dollar Sales for Automated Analyzers, Total LabAutomation, and Stand-alone Automation for Years 2003, 2011,and 2017 (includes corresponding Graph/Chart) III-38
2b. GERMANY III-39
A.Market Analysis III-39
Strategic Corporate Development III-39
B.Market Analytics III-40
Table 25: German Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand-alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-40
Table 26: German Historic Review for Clinical DiagnosticsAutomation by Product Segment - Automated Analyzers, TotalLab Automation, and Stand-alone Automation IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2003 through 2008 (includes corresponding Graph/Chart) III-41
Table 27: German 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-42
2c. ITALY III-43Market Analytics III-43Table 28: Italian Recent Past, Current and Future Analysisfor Clinical Diagnostics Automation by Product Segment -Automated Analyzers, Total Lab Automation, and Stand-aloneAutomation Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-43
Table 29: Italian Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-44
Table 30: Italian 15-Year Perspective for ClinicalDiagnostics Automation by Product Segment - PercentageBreakdown of Dollar Sales for Automated Analyzers, Total LabAutomation, and Stand-alone Automation for Years 2003, 2011,and 2017 (includes corresponding Graph/Chart) III-45
2d. THE UNITED KINGDOM III-46
Market Analytics III-46
Table 31: The UK Recent Past, Current and Future Analysis
for Clinical Diagnostics Automation by Product Segment -
Automated Analyzers, Total Lab Automation, and Stand-alone
Automation Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2009 through 2017 (includes
corresponding Graph/Chart) III-46
Table 32: The UK Historic Review for Clinical DiagnosticsAutomation by Product Segment - Automated Analyzers, TotalLab Automation, and Stand-alone Automation IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2003 through 2008 (includes corresponding Graph/Chart) III-47
Table 33: The UK 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-48
2e. SPAIN III-49Market Analytics III-49Table 34: Spanish Recent Past, Current and Future Analysisfor Clinical Diagnostics Automation by Product Segment -Automated Analyzers, Total Lab Automation, and Stand-aloneAutomation Independently Analyzed with Annual Sales Figuresin US$ Million for Years 2009 through 2017 (includescorresponding Graph/Chart) III-49
Table 35: Spanish Historic Review for Clinical Diagnostics
Automation by Product Segment - Automated Analyzers, Total
Lab Automation, and Stand-alone Automation Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2003 through 2008 (includes corresponding Graph/Chart) III-50
Table 36: Spanish 15-Year Perspective for ClinicalDiagnostics Automation by Product Segment - PercentageBreakdown of Dollar Sales for Automated Analyzers, Total LabAutomation, and Stand-alone Automation for Years 2003, 2011,and 2017 (includes corresponding Graph/Chart) III-51
2f. FEST OF EUROPE III-52
Market Analytics III-52
Table 37: Rest of European Recent Past, Current and Future
Analysis for Clinical Diagnostics Automation by Product
Segment - Automated Analyzers, Total Lab Automation, and
Stand-alone Automation Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2009 through 2017
(includes corresponding Graph/Chart) III-52
Table 38: Rest of European Historic Review for ClinicalDiagnostics Automation by Product Segment - AutomatedAnalyzers, Total Lab Automation, and Stand-alone AutomationIndependently Analyzed with Annual Sales Figures in US$Million for Years 2003 through 2008 (includes correspondingGraph/Chart) III-53
Table 39: Rest of European 15-Year Perspective for Clinical
Diagnostics Automation by Product Segment - Percentage
Breakdown of Dollar Sales for Automated Analyzers, Total Lab
Automation, and Stand-alone Automation for Years 2003, 2011,
and 2017 (includes corresponding Graph/Chart) III-54
3. REST OF WORLD III-55A.Market Analysis III-55Focus on Select Regional Markets III-55Asia-Pacific III-55India III-55Automation of Clinical Laboratories on the RiseIII-55Challenges Abound in the Indian Clinical DiagnosticsLabs Market III-55Diagnostics Arena Witnesses Rapid Transformation III-56Private Enterprises Incite Changes in the Diagnostics Sector III-56Singapore III-56Current & Future Outlook III-56Japan III-57Automation - Past & Present III-57Brazil III-57Clinical Diagnostics Automation Market Poised to Grow III-57Table 40: Brazilian Clinical Diagnostics AutomationMarket (2011): Market Share Breakdown by LeadingCompanies - Siemens Healthcare, Abbott Diagnostics, RocheDiagnostics, and Others (includes correspondingGraph/Chart) III-58South Africa III-58Laboratories Adopt Integrated Systems and CombinedWorkstations III-58Manufacturers' Shifting focus on Ease of Use and EnhancedAutomation Throughput III-58Product Launches III-59Strategic Corporate Development III-59B.Market Analytics III-61Table 41: Rest of World Recent Past, Current and FutureAnalysis for Clinical Diagnostics Automation by ProductSegment - Automated Analyzers, Total Lab Automation, andStand-alone Automation Independently Analyzed with AnnualSales Figures in US$ Million for Years 2009 through 2017(includes corresponding Graph/Chart) III-61
Table 42: Rest of World Historic Review for Clinical
Diagnostics Automation by Product Segment - Automated
Analyzers, Total Lab Automation, and Stand-alone Automation
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2003 through 2008 (includes corresponding
Graph/Chart) III-62
Table 43: Rest of World 15-Year Perspective for ClinicalDiagnostics Automation by Product Segment - PercentageBreakdown of Dollar Sales for Automated Analyzers, Total LabAutomation, and Stand-alone Automation for Years 2003, 2011,and 2017 (includes corresponding Graph/Chart) III-63IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 62 (including Divisions/Subsidiaries - 68)
------------------------------------------Region/Country Players------------------------------------------The United States 40Canada 3Europe 22France 3Germany 4The United Kingdom 6Rest of Europe 9Asia-Pacific (Excluding Japan) 3------------------------------------------
To order this report:In Vitro Diagnostic Industry: Global Clinical Diagnostics Automation IndustryCheck our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article